Low-dose taurine upregulates taurine transporter expression in acute myocardial ischemia

被引:18
作者
Zhang, Yue [1 ]
Yang, Lin [2 ]
Yang, Yu-Jie [3 ]
Liu, Xiao-Yu [3 ]
Jia, Jian-Guo [1 ]
Qian, Ju-Ying [1 ]
Wang, Ke-Qiang [1 ]
Zuo, Ji [3 ]
Ge, Jun-Bo [1 ]
机构
[1] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Dept Cardiol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Eye & ENT Hosp, Shanghai 200032, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Dept Cellular & Genet Med, Shanghai 200032, Peoples R China
关键词
taurine; taurine transporter; acute myocardial ischemia; hypoxia; CONGESTIVE HEART-FAILURE; BIOSYNTHETIC-ENZYMES; OXIDATIVE STRESS; FUNCTIONAL-CHARACTERIZATION; GENE-EXPRESSION; MESSENGER-RNA; RAT; PREVENTS; APOPTOSIS; LOCALIZATION;
D O I
10.3892/ijmm.2013.1264
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Taurine exerts a protective effect on cardiomyocytes. The aim of this study was to determine whether the protective effect of taurine is associated with the upregulation of taurine transporter (TAUT) expression in acute myocardial ischemia (AMI). To this end, we investigated TAUT expression in cultured cardiomyocytes exposed to hypoxia as well as in rats with AMI treated with or not with taurine. The morphology of cardiac tissues, the apoptosis of cardiomyocytes and cardiac function were examined. In addition, the taurine content and the expression of TAUT were measured. Our data demonstrated that taurine reversed the apoptosis induced by hypoxia and AMI, thereby, effectively protecting the myocardium. Taurine content and TAUT expression levels were significantly decreased when cardiomyocytes and cardiac tissues were subjected to hypoxic or ischemic stress, while the expression of cysteine sulfinate decarboxylase was unchanged. Moreover, treatment with taurine (100 mg/kg/day) significantly upregulated TAUT expression and elevated the taurine content in ischemic myocardial tissues. In vitro, the low-dose (40 mM) but not the high-dose (120 mM) administration of taurine significantly induced TAUT expression and elevated the intracellular taurine content in hypoxic cardiomyocytes. In conclusion, our data demonstrate that taurine exerts a protective effect on the ischemic myocardium. Low-dose but not high-dose taurine treatment upregulated TAUT expression and increased the intracellular taurine content in cardiomyocytes subjected to hypoxia as well as in AMI tissues.
引用
收藏
页码:817 / 824
页数:8
相关论文
共 32 条
[1]  
[Anonymous], 2004, GLOB BURD DIS 2004 U, P146, DOI [DOI 10.1038/NPP.2011.85, 10.1038/npp.2011.85]
[2]   THERAPEUTIC EFFECT OF TAURINE IN CONGESTIVE HEART-FAILURE - A DOUBLE-BLIND CROSSOVER TRIAL [J].
AZUMA, J ;
SAWAMURA, A ;
AWATA, N ;
OHTA, H ;
HAMAGUCHI, T ;
HARADA, H ;
TAKIHARA, K ;
HASEGAWA, H ;
YAMAGAMI, T ;
ISHIYAMA, T ;
IWATA, H ;
KISHIMOTO, S .
CLINICAL CARDIOLOGY, 1985, 8 (05) :276-282
[3]  
AZUMA J, 1983, CLIN THER, V5, P398
[4]   Taurine synthesis and cysteine metabolism in cultured rat astrocytes: effects of hyperosmotic exposure [J].
Beetsch, JW ;
Olson, JE .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (04) :C866-C874
[5]   Gene expression of the taurine transporter and taurine biosynthetic enzymes in rat kidney after antidiuresis and salt loading [J].
Bitoun, M ;
Levillain, O ;
Tappaz, M .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2001, 442 (01) :87-95
[6]  
Bitoun M, 2000, GLIA, V32, P165, DOI 10.1002/1098-1136(200011)32:2<165::AID-GLIA60>3.3.CO
[7]  
2-U
[8]   Effects of taurine and homocysteine on calcium homeostasis and hydrogen peroxide and superoxide anions in rat myocardial mitochondria [J].
Chang, L ;
Zhao, J ;
Xu, JX ;
Jiang, W ;
Tang, CS ;
Qi, YF .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (04) :237-243
[9]   TAURINE AND THE HEART [J].
CHAPMAN, RA ;
SULEIMAN, MS ;
EARM, YE .
CARDIOVASCULAR RESEARCH, 1993, 27 (03) :358-363
[10]   Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: Role of NF-κB, p38 and JNK MAPK pathway [J].
Ghosh, Jyotirmoy ;
Das, Joydeep ;
Manna, Prasenjit ;
Sil, Parames C. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 240 (01) :73-87